5-42694985-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000163.5(GHR):c.335G>T(p.Cys112Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C112S) has been classified as Pathogenic.
Frequency
Consequence
NM_000163.5 missense
Scores
Clinical Significance
Conservation
Publications
- Laron syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- short stature due to partial GHR deficiencyInheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000163.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GHR | NM_000163.5 | MANE Select | c.335G>T | p.Cys112Phe | missense | Exon 5 of 10 | NP_000154.1 | ||
| GHR | NM_001242399.2 | c.356G>T | p.Cys119Phe | missense | Exon 5 of 10 | NP_001229328.1 | |||
| GHR | NM_001242400.2 | c.335G>T | p.Cys112Phe | missense | Exon 6 of 11 | NP_001229329.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GHR | ENST00000230882.9 | TSL:1 MANE Select | c.335G>T | p.Cys112Phe | missense | Exon 5 of 10 | ENSP00000230882.4 | ||
| GHR | ENST00000620156.4 | TSL:5 | c.356G>T | p.Cys119Phe | missense | Exon 5 of 10 | ENSP00000483403.1 | ||
| GHR | ENST00000537449.5 | TSL:5 | c.335G>T | p.Cys112Phe | missense | Exon 5 of 10 | ENSP00000442206.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Laron-type isolated somatotropin defect Pathogenic:1
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys112 amino acid residue in GHR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17405847). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GHR protein function. This missense change has been observed in individuals with autosomal recessive Laron syndrome (PMID: 28743110). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 112 of the GHR protein (p.Cys112Phe).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at